Muir-torre Syndrome
Description
Muir-Torre syndrome (MTS) is a form of hereditary nonpolyposis colon cancer (HNPCC) characterized by cutaneous sebaceous tumors, keratoacanthomas and at least one visceral malignancy, most frequently gastrointestinal carcinoma.
Clinical Features
Top most frequent phenotypes and symptoms related to Muir-torre Syndrome
- Neoplasm
- Carcinoma
- Leukemia
- Nevus
- Lymphoma
- Vasculitis
- Hyperlipidemia
- Neoplasm of the skin
- Breast carcinoma
- Basal cell carcinoma
And another 21 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Muir-torre Syndrome Is also known as cutaneous sebaceous neoplasms and keratoacanthomas, multiple, with gastrointestinal and other carcinomas, multiple keratoacanthoma, muir-torre type.
Researches and researchers
Doctors, researchs, and experts related to Muir-torre Syndrome extracted from public data.
Muir-torre Syndrome Experts map
Current Researchs and researchers
-
HALLE (SAALE) — Pr Wolfgang G. BALLHAUSEN
Responsible for diagnostic tests - Investigator of research project
-
Institution/s:
— Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg -
Research area/topic::
The function of fragile histidine triad gene (FHIT) gene in Muir-Torre syndrome and other tumors
-
Institution/s:
Muir-torre Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
HNPCC MSI & IHC Screening.
By Baylor Miraca Genetics Laboratories (United States).
EPCAM, MLH1, MSH2, MSH6, PMS2
Specificity
60 %
Genes
100 % |
MSH6 Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
MSH6
Specificity
100 %
Genes
34 % |
MSH6 Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
MSH6
Specificity
100 %
Genes
34 % |
MSH6 Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
MSH6
Specificity
100 %
Genes
34 % |
MSH6 Sequence Analysis (Familial Mutation/Variant Analysis).
By Baylor Miraca Genetics Laboratories (United States).
MSH6
Specificity
100 %
Genes
34 % |
Mismatch Repair Proteins Immunohistochemistry.
By Baylor Miraca Genetics Laboratories (United States).
MLH1, MSH2, MSH6, PMS2
Specificity
75 %
Genes
100 % |
Hereditary Brain, CNS, PNS Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
18 %
Genes
100 % |
Hereditary Brain, CNS, PNS Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
18 %
Genes
100 % |
You can get up to 470 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH ORPHANET OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SKRABAN-DEARDORFF SYNDROME; SKDEAS MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC